Skip to content

Labor Epidural Analgesia and Mother-Infant Bonding After Vaginal Delivery

Association Between Postpartum Recovery Quality Measured by ObsQoR-10 and Mother-Infant Bonding After Vaginal Delivery: The Role of Labor Epidural Analgesia

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07582289
Enrollment
140
Registered
2026-05-12
Start date
2026-05-15
Completion date
2029-06-17
Last updated
2026-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor Pain, Mother-infant Bonding, Postpartum Recovery

Keywords

Labor Epidural Analgesia, Postpartum Bonding Questionnaire, PBQ, EPDS, STAIS-5, ObsQoR-10, Vaginal Birth, Postpartum Recovery, Maternal Bonding, Obstetric Anesthesia, Postpartum Anxiety, Postpartum Depression

Brief summary

This prospective observational cohort study aims to evaluate the association between postpartum recovery quality and mother-infant bonding in women undergoing vaginal delivery. Postpartum recovery quality will be assessed using the Obstetric Quality of Recovery-10 (ObsQoR-10) questionnaire, and mother-infant bonding will be evaluated using the Postpartum Bonding Questionnaire (PBQ). Participants will be grouped according to routine clinical labor analgesia preference: women receiving labor epidural analgesia and women not receiving epidural analgesia. Additional assessments will include postpartum pain intensity, anxiety, depressive symptoms, and birth satisfaction. Baseline psychological assessments will be performed before delivery. The primary postpartum evaluation will be conducted between 6 and 24 hours after delivery. Exploratory follow-up assessments will be performed by telephone during postpartum week 2. The study aims to better understand the relationship between labor analgesia, postpartum recovery, and early mother-infant bonding outcomes after vaginal delivery.

Detailed description

This single-center prospective observational cohort study will be conducted at Atatürk University Research Hospital. The study will include term pregnant women planning vaginal delivery. Participants will be classified into two cohorts according to routine clinical labor analgesia preference: Women receiving labor epidural analgesia Women not receiving labor epidural analgesia No experimental intervention will be applied as part of the study protocol. Epidural analgesia, when used, will be administered according to routine clinical practice. Primary Objective: To evaluate the association between postpartum recovery quality measured using the ObsQoR-10 questionnaire and mother-infant bonding measured using the Postpartum Bonding Questionnaire (PBQ), and to investigate the role of labor epidural analgesia in this relationship. Secondary Objectives: To compare postpartum recovery quality between cohorts To compare mother-infant bonding outcomes between cohorts To evaluate postpartum pain, anxiety, depressive symptoms, and birth satisfaction To assess the association between obstetric variables and postpartum recovery outcomes Assessments: Prepartum: STAIS-5 EPDS Early postpartum period (6-24 hours): ObsQoR-10 PBQ STAIS-5 EPDS Pain score (VAS/NRS) Birth satisfaction Likert scale Postpartum week 2: PBQ EPDS Participants will provide written informed consent before enrollment. All collected data will be anonymized and analyzed confidentially.

Interventions

PROCEDURELabor Epidural Analgesia

Epidural analgesia administered during labor as part of routine clinical care for pain management during vaginal delivery.

Sponsors

Ataturk University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Female participants aged 18 to 40 years * Term singleton pregnancy (≥37 weeks) * Planned vaginal delivery * ASA physical status II * Ability to understand Turkish * Written informed consent

Exclusion criteria

* Contraindications to epidural analgesia including coagulopathy, anticoagulant use, infection, or increased intracranial pressure * Cesarean delivery * High-risk pregnancy * Neonatal intensive care unit requirement * Major depressive disorder * Anxiety disorder * Current psychotropic medication use

Design outcomes

Primary

MeasureTime frameDescription
Mother-Infant Bonding Score6 to 24 hours after vaginal deliveryMother-infant bonding will be assessed using the Postpartum Bonding Questionnaire (PBQ), a 25-item scale with a total score ranging from 0 to 125. Lower scores indicate better mother-infant bonding, while higher scores indicate poorer bonding.

Secondary

MeasureTime frameDescription
Postpartum Recovery Quality Score6 to 24 hours after vaginal deliveryPostpartum recovery quality will be assessed using the Obstetric Quality of Recovery-10 (ObsQoR-10) questionnaire. Higher scores indicate better postpartum recovery quality.
Postpartum Pain Intensity6 to 24 hours after vaginal deliveryPostpartum pain intensity will be assessed using the Visual Analog Scale (VAS) or Numeric Rating Scale (NRS).
Postpartum Anxiety Level6 to 24 hours after vaginal deliveryPostpartum anxiety level will be assessed using the STAIS-5 questionnaire.
Postpartum Depressive Symptoms6 to 24 hours after vaginal deliveryPostpartum depressive symptoms will be assessed using the Edinburgh Postnatal Depression Scale (EPDS).
Birth Satisfaction Score6 to 24 hours after vaginal deliveryBirth satisfaction will be assessed using a 4-point Likert scale.
Mother-Infant Bonding at Postpartum Week 22 weeks after vaginal deliveryMother-infant bonding will be reassessed using the Postpartum Bonding Questionnaire (PBQ) during telephone follow-up at postpartum week 2.
Postpartum Depressive Symptoms at Week 22 weeks after vaginal deliveryPostpartum depressive symptoms will be reassessed using the Edinburgh Postnatal Depression Scale (EPDS) during telephone follow-up at postpartum week 2.

Countries

Turkey (Türkiye)

Contacts

CONTACTAyşenur Dostbil, Associate Professor
adostbil@hotmail.com+90 533 367 66 96
CONTACTAyşe Ceren Hilal Güven, assistant doctor
achg1995@gmail.com+90 554 112 25 81
STUDY_CHAIRAyşe Ceren Hilal Güven, assistant doctor

Ataturk University Department of Anesthesiology and Reanimation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 4, 2026